Browsing by Author "Budambula, Valentine"
Now showing items 1-4 of 4
-
Clinical chemistry profiles in injection heroin users from Coastal Region, Kenya
Were, Tom; Wesongah, Jesca O; Munde, Elly; Ouma, Collins; Kahiga, Titus M; Owuor, Francisca O; Kiarie, James N; Ahmed, Aabid A; Makokha, Ernest P; Budambula, Valentine (Biomed central, 2014-07-09)Background Although the co-burden of injection drug use and HIV is increasing in Africa, little is known about the laboratory markers of injection drug use and anti-retroviral treatment (ART) in Kenyan injection drug ... -
Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya
Webale, Mark K; Budambula, Valentine; Lihana, Raphael; Musumba, Francis O; Nyamache, Anthony K; Budambu, Nancy LM; Ahmed, Aabid A; Ouma, Collins; Were, Tom (BioMed Central, 2015-07-30)Background Information about HBV sero-markers, infection stages and genotypes in HIV-1 infected and uninfected injection and non-injection drug users (IDUs) in Kenya remains elusive. Methods A cross-sectional study ... -
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and-experienced injection drug users and non-drug users
Budambula, Valentine; Musumba, Francis O; Webale, Mark K; Kahiga, Titus M; Owuor, Francisca O; Kiarie, James N; Sowayi, George A; Ahmed, Aabid A; Ouma, Collins; Were, Tom (BioMed Central, 2015-08-15)Background Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations ... -
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and-experienced injection drug users and non-drug users
Budambula, Valentine; Musumba, Francis O; Webale, Mark K; Kahiga, Titus M; Owuor, Francisca O; Kiarie, James N; Sowayi, George A; Ahmed, Aabid A; Ouma, Collins; Were, Tom (BioMed Central, 2015-08-11)Background Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations ...